Format

Send to

Choose Destination

See 1 citation found using an alternative search:

Anticancer Res. 2016 Nov;36(11):5639-5647.

Molecular Mechanisms of Anti-metastatic Activity of Curcumin.

Author information

1
University of Sydney, Faculty of Pharmacy, Sydney, Australia.
2
Université de Nantes, UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France.
3
University of Sydney, Faculty of Pharmacy, Sydney, Australia ramin.rohanizadeh@sydney.edu.au.

Abstract

Cancer is the leading cause of death worldwide. Although cancer occurs as a localized disease, its morbidity and mortality rates remain high due to the ability of cancer cells to break-off from the primary tumor and spread to distant organs. Currently, chemotherapy is the main treatment for cancer; however, the increase in proportion of drug-resistant cancer cells and unpleasant side-effects of chemotherapy are still the major challenges in cancer therapy. Curcumin is a natural polyphenol compound and the main bioactive constituent of Indian spice turmeric, widely used in Indian and Chinese medicines. Curcumin has well-known therapeutic actions, including anti-inflammatory, anti-microbial, anti-oxidant and anti-cancer properties. Curcumin induces cancer cell apoptosis through regulating various signaling pathways and arresting tumor cell cycle. Curcumin's therapeutic/ preventative actions on metastatic cancers have not been yet fully understood and studied. The present review explores the potential anti-metastatic mechanisms of curcumin, including inhibition of transcription factors and their signaling pathways (e.g., NF-κB, ApP-1 and STAT3), inflammatory cytokines (e.g., CXCL1, CXCL2, IL-6, IL-8), multiple proteases (e.g., uPA, MMPs), multiple protein kinases (e.g., MAPKs, FAK), regulation of miRNAs (e.g., miR21, miR181b) and heat shock proteins (HLJ1). In addition, possible synergistic actions of combination therapy of curcumin with current chemotherapies are discussed in this review.

KEYWORDS:

Curcumin; cancer invasion; cancer treatment and prevention; metastasis; review; signaling pathways

PMID:
27793885
DOI:
10.21873/anticanres.11147
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center